Newly Approved Agents in HER2-Positive Metastatic Breast Cancer with Dr Mark Pegram - a podcast by Research To Practice

Dr Mark Pegram from the Stanford University School of Medicine discusses the latest clinical data on and optimal use of newly approved therapies for HER2-positive metastatic breast cancer.
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayHER2MetastaticBC21).

Further episodes of Oncology Today with Dr Neil Love

Further podcasts by Research To Practice

Website of Research To Practice